Clinical Trial Update: Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the Human Acellular Vessel (HAV) versus standard fistulas for hemodialysis vascular access has completed in patients with end-stage r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Human Acellular Vessel (HAV)

Snippet

Sponsor: Humacyte, Inc. | Conditions: Renal Failure, End Stage Renal Disease | Phase 3 | Status: COMPLETED